TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - JOUR AU - Cheng, A. L. AU - Kang, Y. K. AU - Chen, Z. AU - Tsao, C. J. AU - Qin, S. AU - Kim, J. S. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Dancey, J. AU - Zee, B. AU - Osoba, D. AU - Whitehead, M. AU - Lu, F. AU - Kaizer, L. PY - 1997 DA - 1997// TI - Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group JO - Qual Life Res VL - 6 UR - https://doi.org/10.1023/A:1026442201191 DO - 10.1023/A:1026442201191 ID - Dancey1997 ER - TY - JOUR AU - Braun, D. P. AU - Gupta, D. AU - Staren, E. D. PY - 2011 DA - 2011// TI - Quality of life assessment as a predictor of survival in non-small cell lung cancer JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-353 DO - 10.1186/1471-2407-11-353 ID - Braun2011 ER - TY - JOUR AU - Braun, D. P. AU - Gupta, D. AU - Grutsch, J. F. AU - Staren, E. D. PY - 2011 DA - 2011// TI - Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? JO - Health Qual Life Outcomes VL - 9 UR - https://doi.org/10.1186/1477-7525-9-62 DO - 10.1186/1477-7525-9-62 ID - Braun2011 ER - TY - JOUR AU - Steel, J. L. AU - Geller, D. A. AU - Robinson, T. L. AU - Savkova, A. Y. AU - Brower, D. S. AU - Marsh, J. W. PY - 2014 DA - 2014// TI - Health-related quality of life as a prognostic factor in patients with advanced cancer JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28902 DO - 10.1002/cncr.28902 ID - Steel2014 ER - TY - JOUR AU - Grunwald, V. AU - Soltau, J. AU - Ivanyi, P. AU - Rentschler, J. AU - Reuter, C. AU - Drevs, J. PY - 2009 DA - 2009// TI - Molecular targeted therapies for solid tumors: management of side effects JO - Onkologie VL - 32 ID - Grunwald2009 ER - TY - JOUR AU - Miyake, H. AU - Kurahashi, T. AU - Yamanaka, K. AU - Kondo, Y. AU - Takenaka, A. AU - Inoue, T. A. PY - 2010 DA - 2010// TI - Impact of sorafenib on health-related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation JO - BJU Int VL - 106 UR - https://doi.org/10.1111/j.1464-410X.2010.09437.x DO - 10.1111/j.1464-410X.2010.09437.x ID - Miyake2010 ER - TY - JOUR AU - Trask, P. C. AU - Bushmakin, A. G. AU - Cappelleri, J. C. AU - Bycott, P. AU - Liau, K. AU - Kim, S. PY - 2008 DA - 2008// TI - Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib JO - Acta Oncol VL - 47 UR - https://doi.org/10.1080/02841860802047395 DO - 10.1080/02841860802047395 ID - Trask2008 ER - TY - JOUR AU - Schadendorf, D. AU - Amonkar, M. M. AU - Stroyakovskiy, D. AU - Levchenko, E. AU - Gogas, H. AU - Braud, F. PY - 2015 DA - 2015// TI - Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.03.004 DO - 10.1016/j.ejca.2015.03.004 ID - Schadendorf2015 ER - TY - JOUR AU - Nardone, B. AU - Hensley, J. R. AU - Kulik, L. AU - West, D. P. AU - Mulcahy, M. AU - Rademaker, A. PY - 2012 DA - 2012// TI - The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life JO - J Drugs Dermatol VL - 11 ID - Nardone2012 ER - TY - JOUR AU - Brunocilla, P. R. AU - Brunello, F. AU - Carucci, P. AU - Gaia, S. AU - Rolle, E. AU - Cantamessa, A. PY - 2013 DA - 2013// TI - Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-012-0345-2 DO - 10.1007/s12032-012-0345-2 ID - Brunocilla2013 ER - TY - JOUR AU - Boursier, J. AU - Cesbron, E. AU - Tropet, A. L. AU - Pilette, C. PY - 2009 DA - 2009// TI - Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients JO - J Clin Gastroenterol VL - 43 UR - https://doi.org/10.1097/MCG.0b013e3181889468 DO - 10.1097/MCG.0b013e3181889468 ID - Boursier2009 ER - TY - JOUR AU - Minagawa, M. AU - Ikai, I. AU - Matsuyama, Y. AU - Yamaoka, Y. AU - Makuuchi, M. PY - 2007 DA - 2007// TI - Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan JO - Ann Surg VL - 245 UR - https://doi.org/10.1097/01.sla.0000254368.65878.da DO - 10.1097/01.sla.0000254368.65878.da ID - Minagawa2007 ER - TY - JOUR AU - Oken, M. M. AU - Creech, R. H. AU - Tormey, D. C. AU - Horton, J. AU - Davis, T. E. AU - McFadden, E. T. PY - 1982 DA - 1982// TI - Toxicity and response criteria of the Eastern Cooperative Oncology Group JO - Am J Clin Oncol VL - 5 UR - https://doi.org/10.1097/00000421-198212000-00014 DO - 10.1097/00000421-198212000-00014 ID - Oken1982 ER - TY - JOUR AU - Fukuhara, S. AU - Bito, S. AU - Green, J. AU - Hsiao, A. AU - Kurokawa, K. PY - 1998 DA - 1998// TI - Translation, adaptation, and validation of the SF-36 health survey for use in Japan JO - J Clin Epidemiol VL - 51 UR - https://doi.org/10.1016/S0895-4356(98)00095-X DO - 10.1016/S0895-4356(98)00095-X ID - Fukuhara1998 ER - TY - JOUR AU - Fukuhara, S. AU - Ware, J. E. AU - Kosinski, M. AU - Wada, S. AU - Gandek, B. PY - 1998 DA - 1998// TI - Psychometric and clinical tests of validity of the Japanese SF-36 health survey JO - J Clin Epidemiol VL - 51 UR - https://doi.org/10.1016/S0895-4356(98)00096-1 DO - 10.1016/S0895-4356(98)00096-1 ID - Fukuhara1998 ER - TY - JOUR AU - Lencioni, R. AU - Llovet, J. M. PY - 2010 DA - 2010// TI - Modified RECIST (mRECIST) assessment for hepatocellular carcinoma JO - Semin Liver Dis VL - 30 UR - https://doi.org/10.1055/s-0030-1247132 DO - 10.1055/s-0030-1247132 ID - Lencioni2010 ER - TY - STD TI - Japan Clinical Oncology Group. Common Terminology Criteria for Adverse Events (CTCAE) v4.0-Japan Clinical Oncology Group. 2009. Available at http://www.jcog.jp/doctor/tool/CTCAEv4J_20160310.pdf. Accessed 25 Mar 2016. UR - http://www.jcog.jp/doctor/tool/CTCAEv4J_20160310.pdf ID - ref20 ER - TY - JOUR AU - Bukowski, R. AU - Cella, D. AU - Gondek, K. AU - Escudier, B. PY - 2007 DA - 2007// TI - Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer JO - Am J Clin Oncol VL - 30 UR - https://doi.org/10.1097/01.coc.0000258732.80710.05 DO - 10.1097/01.coc.0000258732.80710.05 ID - Bukowski2007 ER - TY - JOUR AU - Koldenhof, J. J. AU - Witteveen, P. O. AU - Vos, R. AU - Walraven, M. AU - Tillier, C. N. AU - Verheul, H. M. PY - 2014 DA - 2014// TI - Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions JO - Support Care Cancer VL - 22 ID - Koldenhof2014 ER - TY - JOUR AU - Shomura, M. AU - Kagawa, T. AU - Shiraishi, K. AU - Hirose, S. AU - Arase, Y. AU - Koizumi, J. PY - 2014 DA - 2014// TI - Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma JO - World J Hepatol VL - 6 UR - https://doi.org/10.4254/wjh.v6.i9.670 DO - 10.4254/wjh.v6.i9.670 ID - Shomura2014 ER - TY - JOUR AU - Estfan, B. AU - Byrne, M. AU - Kim, R. PY - 2007 DA - 2007// TI - Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy JO - Am J Clin Oncol VL - 36 UR - https://doi.org/10.1097/COC.0b013e3182468039 DO - 10.1097/COC.0b013e3182468039 ID - Estfan2007 ER - TY - JOUR AU - Koschny, R. AU - Gotthardt, D. AU - Koehler, C. AU - Jaeger, D. AU - Stremmel, W. AU - Ganten, T. M. PY - 2013 DA - 2013// TI - Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma JO - Oncology VL - 84 UR - https://doi.org/10.1159/000342425 DO - 10.1159/000342425 ID - Koschny2013 ER - TY - JOUR AU - Yeo, W. AU - Mo, F. K. AU - Koh, J. AU - Chan, A. T. AU - Leung, T. AU - Hui, P. PY - 2006 DA - 2006// TI - Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl065 DO - 10.1093/annonc/mdl065 ID - Yeo2006 ER - TY - JOUR AU - Diouf, M. AU - Filleron, T. AU - Barbare, J. C. AU - Fin, L. AU - Picard, C. AU - Bouché, O. PY - 2013 DA - 2013// TI - The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.11.019 DO - 10.1016/j.jhep.2012.11.019 ID - Diouf2013 ER - TY - JOUR AU - Behrens, G. AU - Matthews, C. E. AU - Moore, S. C. AU - Freedman, N. D. AU - McGlynn, K. A. AU - Everhart, J. E. PY - 2013 DA - 2013// TI - The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study JO - Eur J Epidemiol VL - 28 UR - https://doi.org/10.1007/s10654-013-9767-1 DO - 10.1007/s10654-013-9767-1 ID - Behrens2013 ER - TY - JOUR AU - Ukawa, S. AU - Tamakoshi, A. AU - Wakai, K. AU - Kurozawa, Y. PY - 2014 DA - 2014// TI - Associations of daily walking and television viewing time with liver cancer mortality: findings from the Japan Collaborative Cohort Study JO - Cancer Causes Control VL - 25 UR - https://doi.org/10.1007/s10552-014-0380-8 DO - 10.1007/s10552-014-0380-8 ID - Ukawa2014 ER - TY - JOUR AU - Cron, D. C. AU - Friedman, J. F. AU - Winder, G. S. AU - Thelen, A. E. AU - Derck, J. E. AU - Fakhoury, J. W. PY - 2016 DA - 2016// TI - Depression and frailty in patients with end-stage liver disease referred for transplant evaluation JO - Am J Transplant VL - 16 UR - https://doi.org/10.1111/ajt.13639 DO - 10.1111/ajt.13639 ID - Cron2016 ER - TY - JOUR AU - Lai, J. C. AU - Feng, S. AU - Terrault, N. A. AU - Lizaola, B. AU - Hayssen, H. AU - Covinsky, K. PY - 2014 DA - 2014// TI - Frailty predicts waitlist mortality in liver transplant candidates JO - Am J Transplant VL - 14 UR - https://doi.org/10.1111/ajt.12762 DO - 10.1111/ajt.12762 ID - Lai2014 ER - TY - JOUR AU - Chang, S. F. AU - Lin, P. L. PY - 2015 DA - 2015// TI - Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies JO - Int J Nurs Stud VL - 52 UR - https://doi.org/10.1016/j.ijnurstu.2015.04.005 DO - 10.1016/j.ijnurstu.2015.04.005 ID - Chang2015 ER - TY - JOUR AU - Gill, T. M. AU - Gahbauer, E. A. AU - Han, L. AU - Allore, H. G. PY - 2010 DA - 2010// TI - Trajectories of disability in the last year of life JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909087 DO - 10.1056/NEJMoa0909087 ID - Gill2010 ER - TY - JOUR AU - Sinn, D. H. AU - Cho, J. Y. AU - Gwak, G. Y. AU - Paik, Y. H. AU - Choi, M. S. AU - Lee, J. H. PY - 2015 DA - 2015// TI - Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0124434 DO - 10.1371/journal.pone.0124434 ID - Sinn2015 ER - TY - JOUR AU - Miyahara, K. AU - Nouso, K. AU - Morimoto, Y. AU - Tomoda, T. AU - Kobayashi, S. AU - Takeuchi, Y. PY - 2013 DA - 2013// TI - Evaluation of the effect of sorafenib using serum NX-des-γ-carboxyprothrombin in patients with hepatocellular carcinoma JO - Hepatol Res VL - 43 ID - Miyahara2013 ER - TY - JOUR AU - Farinati, F. AU - Vitale, A. AU - Spolverato, G. AU - Pawlik, T. M. AU - Huo, T. L. AU - Lee, Y. H. PY - 2016 DA - 2016// TI - Development and validation of a new prognostic system for patients with hepatocellular carcinoma JO - PLoS Med VL - 13 UR - https://doi.org/10.1371/journal.pmed.1002006 DO - 10.1371/journal.pmed.1002006 ID - Farinati2016 ER - TY - JOUR AU - Forner, A. AU - Llovet, J. M. AU - Bruix, J. PY - 2012 DA - 2012// TI - Hepatocellular carcinoma JO - Lancet VL - 31 UR - https://doi.org/10.1016/S0140-6736(11)61347-0 DO - 10.1016/S0140-6736(11)61347-0 ID - Forner2012 ER - TY - JOUR AU - Montella, L. AU - Addeo, R. AU - Cennamo, G. AU - Vincenzi, B. AU - Palmieri, R. AU - Sperlongano, P. PY - 2013 DA - 2013// TI - Sorafenib in elderly patients with advanced hepatocellular carcinoma: a case series JO - Oncology VL - 84 UR - https://doi.org/10.1159/000345558 DO - 10.1159/000345558 ID - Montella2013 ER -